Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Seoul

Seoul, South KoreaNot linked to an institution yet

8running trials
3closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Recruiting
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
NCT07475806· Phase 2· Source
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154· Phase 2· Source
Recruiting
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
NCT06902545· Source
Recruiting
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
NCT06011954· Source
Active, not recruiting
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163· Phase 2· Source
Active, not recruiting
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507· Phase 3· Source
Active, not recruiting
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397· Phase 3· Source
Active, not recruiting
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
NCT02960022· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Bladder cancer2 recruiting
Childhood cancers2 recruiting
Prostate cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
NCT03474107· Phase 3· Source
Completed
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
NCT02677896· Phase 3· Source
Completed
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
NCT02310321· Phase 1/2· Source

Site data: ClinicalTrials.govUpdated 5 Nov 2026

Report an error